लोड हो रहा है...
Utility and risk of dermatologic medications during the COVID‐19 pandemic
In the era of staggering speed in development of the novel coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), we have reviewed the dermatologists' tools at hand for their utility (and potential risks) in patients affected by COVID‐19....
में बचाया:
| में प्रकाशित: | Dermatol Ther |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Inc.
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7323423/ https://ncbi.nlm.nih.gov/pubmed/32537852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13833 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|